Download full Guides to the evaluation of permanent impairment, sixth edition 6th ebook all chapters

Page 1


Guides to the Evaluation of Permanent Impairment, Sixth Edition 6th

Visit to download the full and correct content document: https://ebookmass.com/product/guides-to-the-evaluation-of-permanent-impairment-si xth-edition-6th/

More products digital (pdf, epub, mobi) instant download maybe you interests ...

Guides to the Evaluation of Permanent Impairment, fourth edition 4th Edition, (Ebook PDF)

https://ebookmass.com/product/guides-to-the-evaluation-ofpermanent-impairment-fourth-edition-4th-edition-ebook-pdf/

Guides to the Evaluation of Permanent Impairment, fifth edition 5 Sub Edition, (Ebook PDF)

https://ebookmass.com/product/guides-to-the-evaluation-ofpermanent-impairment-fifth-edition-5-sub-edition-ebook-pdf/

AMA Guides to the Evaluation of Disease and Injury Causation, Second Edition 2nd Revised ed. Edition, (Ebook PDF)

https://ebookmass.com/product/ama-guides-to-the-evaluation-ofdisease-and-injury-causation-second-edition-2nd-revised-ededition-ebook-pdf/

Program Evaluation: An Introduction to an EvidenceBased Approach 6th Edition

https://ebookmass.com/product/program-evaluation-an-introductionto-an-evidence-based-approach-6th-edition/

Publication Manual of the American Psychological Association, Sixth Edition 6th Edition, (Ebook PDF)

https://ebookmass.com/product/publication-manual-of-the-americanpsychological-association-sixth-edition-6th-edition-ebook-pdf/

(eBook PDF) Looking at Movies Sixth Edition 6th Edition

https://ebookmass.com/product/ebook-pdf-looking-at-movies-sixthedition-6th-edition/

Masonry Design and Detailing Sixth Edition 6th Edition, (Ebook PDF)

https://ebookmass.com/product/masonry-design-and-detailing-sixthedition-6th-edition-ebook-pdf/

Commercial Aviation Safety, Sixth Edition 6th Edition –Ebook PDF Version

https://ebookmass.com/product/commercial-aviation-safety-sixthedition-6th-edition-ebook-pdf-version/

Test Bank for Compensation Sixth Canadian Edition (6th) Margaret Yap

https://ebookmass.com/product/test-bank-for-compensation-sixthcanadian-edition-6th-margaret-yap/

Contributors

Senior Contributing Editor

Christopher R. Brigham, MD, MMS

Brigham and Associates, Inc. San Diego, California

Contributing Editors

Marjorie Eskay-Auerbach, MD, JD Tucson, Arizona

Mark H. Hyman, MD, FACP, FAADEP

Associate Clinical Professor of Medicine, UCLA Los Angeles, California

Chapter Contributors

Gunnar B. J. Andersson, MD, PhD Rush University Medical Center Chicago, Illinois

Robert J. Barth, PhD Parkridge Hospital Plaza Chattanooga, Tennessee

Christopher R. Brigham, MD, MMS Brigham and Associates Portland, Maine

Joel V. Brill, MD Predictive Health, LLC Scottsdale, Arizona

Charles N. Brooks, MD, FAADEP Bellevue, Washington

Scott Brown, MD Sinai Hospital of BaltimoreSinai Rehabilitation Center Baltimore, Maryland

Neil A. Busis, MD Pittsburgh Neurological Center Pittsburgh, Pennsylvania

August Colenbrander, MD The Smith-Kettlewell Eye Research Institute and California Pacific Medical Center San Francisco, California

Stephen L. Demeter, MD, MPH, FAADEP

Honolulu Sports Medical Clinic Honolulu, Hawaii

Lorne K. Direnfeld, MD, FRCP (C) Kahului, Hawaii

Robert A. Dobie, MD University of California, Davis Sacramento, California

Leon Ensalada, MD, MPH John F. Kennedy Special Warfare Center and School Fort Bragg, North Carolina

Marjorie Eskay-Auerbach, MD, JD Tucson, Arizona

Eugene P. Frenkel, MD University of Texas Southwestern Medical Center Dallas, Texas

Robert J. Gatchel, PhD, ABPP Department of Psychology College of Science The University of Texas at Arlington

Elizabeth Genovese, MD, MBA, FACOEM, FAADEP

IMX Medical Management Services Bala Cynwyd, Pennsylvania

Mark H. Hyman, MD, FACP, FAADEP

Associate Clinical Professor of Medicine, UCLA Los Angeles, California

Harold E. Hoffman, MD, FRCPC, FACOEM

Meadowlark Place Professional Centre Edmonton, Alberta, Canada

Richard T. Katz, MD Professor of Clinical Neurology (PM&R) Washington University School of Medicine St. Louis, Missouri

Randall D. Lea, MD, FAADEP Center of Orthopedic Care & Evaluation Medicine Baton Rouge, Louisiana

Barry S. Levinson, MD University of Texas Southwestern Medical Center Dallas, Texas

Leonard N. Matheson, PhD Epic Rehab Chesterfield, Missouri

Tom G. Mayer, MD

Productive Rehabilitation Institute of Dallas for Ergonomics (PRIDE) Dallas, Texas

J. Mark Melhorn, MD, FAADEP

The Hand Center

Clinical Assistant Professor Section of Orthopaedics Department of Surgery University of Kansas School of Medicine Wichita, Kansas

Vert Mooney, MD San Diego, California

Kathryn L. Mueller, MD, MPH University of Colorado Health Sciences Center Denver, Colorado

William Nemeth, MD, FAADEP Austin, Texas

Alan K. Novick, MD Hollywood, Florida

Karin A. Pacheco, MD, MSPH National Jewish Medical and Research Center Denver, Colorado

Brooke S. Parish, MD University of New Mexico Albuquerque, New Mexico

Inder Perkash, MD, FACS, FRCS Palo Alto, California

Glenn Pfeffer, MD

Cedars-Sinai Medical Center Los Angeles, California

Peter B. Polatin, MD Dallas, Texas

Gregory Powell, MD Associated Orthopedics & Sports Medicine Plano, Texas

Mohammed I. Ranavaya, MD, JD

Marshall University, Joan C. Edwards School of Medicine Huntington, West Virginia

James P. Rathmell, MD

MGH Pain Center

Massachusetts General Hospital Harvard Medical School Boston, Massachusetts

James P. Robinson, MD, PhD

Clinical Associate Professor Department of Rehabiliation Medicine

University of Washington Seattle, Washington

Robert D. Rondinelli, MD, PhD Medical Director of Rehabilitation Services

Iowa Health Des Moines Des Moines, Iowa

Robert T. Sataloff, MD, DMA, FACS

Professor and Chairman Department of Otolaryngology Drexel University College of Medicine Philadelphia, Pennsylvania

Marcia Scott, MD Cambridge, Massachusetts

William Shaw, MD, FAADEP Denver, Colorado

Naomi N. Shields, MD Wichita, Kansas

Stacey L. Smith, MD

Washington University School of Medicine St. Louis, Missouri

Joel S. Steinberg, MD Willoughby, Ohio

Richard Strain, Jr., MD Hollywood, Florida

James B. Talmage, MD

Occupational Health Center, LLC Cookeville, Tennessee

Russell L. Travis, MD, FAADEP Cardinal Hill Hospital Lexington, Kentucky

Nancy Webb, MD Kelsey-Seybold Clinic Houston, Texas

Paulette S. Wehner, MD Professor and Chief, Division of Cardiovascular Medicine

Marshall University, Joan C. Edwards School of Medicine Huntington, West Virginia

Stephen Wetmore, MD, MBA Professor and Chair Department of Otolaryngology

West Virginia University of School of Medicine Morgantown, West Virginia

Richard D. Wetzel, MD St. Louis, Missouri

Sean Yutzy, MD University of New Mexico Health Sciences Center Albuquerque, New Mexico

Matthew J. Zirwas, MD Ohio State University School of Medicine Columbus, Ohio

Reviewers

Jean-Jacques Abitbol, MD San Diego, California

Charles S. Abrams, MD Philadelphia, Pennsylvania

Victor Adlin, MD Philadelphia, Pennsylvania

Alex Ambroz, MD, MPH Martinsburg, West Virginia

Paul D. Anderson, MD Castroville, California

Gerald Aronoff, MD, DABPM Charlotte, North Carolina

Leonard B. Alenick, MD Lakewood, Washington

Christine Baker, MA Berkeley, California

George W. Balfour Van Nuys, California

Robert J. Barth, PhD, FNAN Chattanooga, TN

Donald R. Barthel, JD Sacremento, California

Janet A. Bertness, JD, ScM. Providence, Rhode Island

Peter V. Bieri, MD Lawrence, Kansas

Martin Black, MD Philadelphia, Pennsylvania

William Blair, MD Woodway, Texas

Bernard R. Blais, MD Clifton Park, New York

Ronald J. Bloomfield, MD Columbus, Ohio

Zachary Bloomgarden, MD New York, NY

William C. Boeck, MD Santa Monica, California

Richard P. Bonfiglio, MD Physical Medicine and Rehabilitation Murrysville, Pennsylvania

Robert Bonner, MD, MPH Hartford, Connecticut

William Boucher, MD, MPH, FACOEM South Portland, Maine

Søren Brage, MD, PhD Oslo, Norway

Glen A. Brasseur, DC, RN Fort Worth, Texas

Donald P. Brobst, MD Birmingham, Alabama

Charles Brooks, MD Bellevue, Washington

Sherri P. Brown, Esq., BS, JD Lexington, Kentucky

Daniel Bruns, PsyD Greeley, Colorado

Robert T. Buchanan, MD Highlands, North Carolina

Frederick W. Burgess, MD, PhD Providence, RI

John F. Burton, Jr., PhD Economics, BS, LLB Princeton, New Jersey

Greg B. Cairns, JD Denver, Colorado

Ross W. Cairns Melbourne, Victoria, Australia

Francis I. Catlin, MD, ScD Houston, Texas

James C. Causey, Jr., JD Seattle, Washington

Jennifer Christian, MD, MPH Wayland, Massachussetts

Robert A. Cohen, MD, FCCP Chicago, Illinois

Charles R. Crane, MD Dallas, Texas

Robert O. Crapo, MD Salt Lake City, Utah

Chris Cunneen, MBBS, FRACGP Medical Advisor, Q-Comp Brisbane, Old, Australia

Paul R. Dionne, JD Lewiston, Maine

Lorne K. Direnfeld, MD, FRCP (C) Kahului, Hawaii

Anthony J. Dorto, DC, MD Miami, Florida

Dwight K. Dowda, MB BS, MPH, FAFOM, FACOEM, FAADEP Sydney, NSW, Australia

Mark A. Doyne, MD, FAAOS, FAADEP, FACPE Dallas, Texas

Joseph P. Drozda, Jr., MD St. Louis, Missouri

Leon Ensalada, MD, MPH Waitsfield, Vermont

Paul E. Epstein, MD Philadelphia, Pennsylvania

Marjorie Eskay-Auerbach, MD, JD Tucson, Arizona

Barbara A. Esses, MD Denver, Colorado

Steven D. Feinberg, MD Palo Alto, California

William D. Frey, PhD Rockville, Maryland

Bert S. Furmansky, MD, MPA Denver, Colorado

John J. Gerhardt, MD Portland, Oregon

Howard H. Goldman, MD, PhD Baltimore, Maryland

Martin Grabois, MD Houston, Texas

Bruce A. Guberman, MD Huntington, West Virginia

Scott Haldeman, DC, MD, PhD, FRCP (C) Santa Ana, California

Luann Haley, JD Tucson, Arizona

Philip Harber, MD, MPH Los Angeles, California

R. Norman Harden, MD Chicago, Illinois

Larry Herron, MD San Luis Obispo, California

Jay Himmelstein, MD, MPH Shrewsbury, Massachusetts

Sue Anne Howard, Esq., BA, JD Morgantown, West Virginia

J. David Hubbard, RN Dallas, Texas

Mark H. Hyman, MD, FACP, FAADEP Los Angeles, California

Richard Kahman, MD Santa Barbara, California

Stanley S. Kaplan DC, DABCO Cocoa Beach, Florida

Morton Kasdan, MD Louisville, Kentucky

Kenneth B. Kauvar, MD Denver, Colorado

Kenneth Kingdon, JD, LLM Rancho Palos Verdes, California

David M. Klein, MD Port Charlotte, Florida

E. Klimek, MD, FRCPC FAADEP St. Catharines, Ontario, Canada

Randall D. Lea, MD Baton Rouge, Louisiana

Norma J. Leclair, PhD, RN Gray, Maine

Steven W. Leclair, PhD Gray, Maine

Philip C. Lening, BA, DC Houston, Texas

Gideon Letz, MD, MPH Stinson Beach, California

William Levasseur, JD Baltimore, Maryland

Philip Levy, MD Phoenix, Arizona

Alan Lipkin, MD Denver, Colorado

Philipp M. Lippe, MD, FACS, FACPM San Jose, California

James Luck, Jr, MD Los Angeles, California

Patrick R. Luers, MD Sandy, Utah

Arthur Lurvey, MD, FACP, FACE Los Angeles, California

Janis H. Malan, Esq. Hunt Valley, Maryland

Peter J. Mandell, MD Burlingame, California

Douglas W. Martin, MD, FAADEP, FACOEM, FAAFP North Sioux City, South Dakota

Robert J. Masone, MD, DABPM Lancaster, Ohio

Annyce Mayer, MD, MSPH Denver, Colorado

Todd McFarren, BA, MA, JD Watsonville, California

Roy T. McKay, PhD Cincinnati, Ohio

Thomas Blair Megowan, BA Los Angeles, California

Frank M. Messana, DO, CIME Gary, Indiana

Ali Reza Moattari, MD Newport Coast, California

Peter A. Moskovitz, MD Washington, DC

William E. Narrow, MD, MPH Arlington, Virgina

Ellen K. Oakes, OTR Denver, Colorado

Fred H. Olin, MD San Antonio, Texas

Steve R. Ommen, MD Rochester, Minnesota

Richard K. Osenbach, MD Durham, North Carolina

Cornelius Passani, MD Santa Barbara, California

Scott J. Primack, MD Englewood, Colorado

John D. Pro, MD, CIME Lee’s Summit, Missouri

David C. Randolph, MD, MPH, FAADEP Cincinnati, Ohio

Carrie A. Redlich, MD, MPH New Haven, Connecticut

Michael M. Romash, MD Chesapeake, Virginia

Charles R. Rondeau, JD, BA Los Angeles, California

Jacob Rosenweig, MD, PhD Delray Beach, Florida

Henry J. Roth, MD Denver, Colorado

Debra H. Rowse, MD, MS Scottsdale, Arizona

David Schenkar, MD Hailey, Idaho

Andrew Sew Hoy, MD Los Angeles, California

Stanley L. Schrier, MD Stanford, California

Raymond J. Schumacher, MD, MPH Tucson, Arizona

William S. Shaw, MD Denver, Colorado

Lisa M. Shulman, MD Baltimore, Maryland

Mitchel U. Silverman, MD Sherman Oaks, California

Roy L. Silverstein, MD Cleveland, Ohio

Dorsett D. Smith, MD, FACP, FCCP, FACOEM Carefree, Arizona

Ralph S. Smith, Jr, MD, MBA Charleston, West Virginia

Lee T. Snook, Jr, MD, DAAPM, FACP Sacramento, California

Trevor Soergel, MD Indianapolis, Indiana

E. Randolph Soo Hoo, MD, MPH, FACOEM Tucson, Arizona

Henry Stockbridge, MD, MPH Olympia, Washington

Daniel Y. Sumner, JD Tallahassee, Florida

D. Lachlan Taylor, JD Oakland, California

Marc T. Taylor, MD San Antonio, Texas

Lloyd Toft, MBBS Brisbane, Australia

David B. Torrey, JD Pittsburgh, Pennsylvania

Mary C. Townsend, DrPH Pittsburgh, Pennsylvania

Russell Travis, MD Lexington, Kentucky

Jon B. Tucker, MD Pittsburgh, Pennsylvania

Craig Uejo, MD, MPH, CIME San Diego, California

Schneider Urs, MD, MBA Zurich, Switzerland

Nancy L. Von Ruden, BS Owatonna, Minnesota

Gordon Waddell, CBE, DSc, MD, FRCS Cardiff, United Kingdom

Paul E Wakim, DO, FAAOOS Huntington Beach, California

Pamela A. Warren, PhD Urbana, Illinois

Izak F. Wessels, MD, FRCSE, FRCOphth, FACS Chattanooga, Tennessee

Alan G. Zacharia, MD Daly City, California

Edward G. Zurad, MD Tunkhannock, Pennsylvania

Table of Contents

1.2 New Directions for the Sixth Edition

1.3 The International Classification of Functioning, Disability, and Health (ICF): A Contemporary Model of Disablement

1.6 The Case for Simplification and Ease of Application

1.7 The Application of Functional Assessment

1.8 The Need for Internal Consistency and a Uniform Template

CHAPTER 3

Controversies Surrounding Pain-Related Impairment

3.3 The Rating System

3.4 Future Directions—Need for Research and Dialogue to Establish the Validity of Rating Pain-Related Impairment

3.5 Conclusion

3.6 Examples

3.7 Appendixes.

Principles of Assessment

2.1 Use of the Guides in Workers’ Compensation and Other Disability Systems

2.2 Organ System and Whole Body Approach to Impairment Ratings

2.3 Use of the Guides

2.4 Rules of Application for the Guides

2.5 Concepts Important to the Independent Medical Examiner

2.6 Impairment Evaluation and the Law

2.7 Preparing Reports

Vascular Diseases Affecting the Extremities

Diseases of the Pulmonary Artery

4.10 Cardiovascular Impairment Evaluation Summary

CHAPTER 5

The Pulmonary System

5.1 Assessing the Pulmonary System

5.2 Clinical Presentation of Pulmonary Disease . . .78

5.3 Environmental Exposures, Lifestyle Choices, and Pulmonary Disease

5.4 Clinical Evaluation, Imaging Studies, and Other Tests for Evaluating Pulmonary Disease

5.5 Methodology for Determining the Grade in an Impairment Class

5.6 Asthma and Other Hyperreactive Airway Diseases .

5.7 Hypersensitivity Pneumonitis

5.8 Pneumoconiosis .

5.9 Lung Cancer

5.10 Sleep Disorders and Other Impairments Related to Pulmonary System

5.11 Examples of Impairment due to Pulmonary Disorders

5.12 Pulmonary Impairment Evaluation Summary

6.1 Principles

6.3

6.5 Liver and Biliary Tract

.80

7.2 The Urinary System

7.3 Upper Urinary Tract

7.4 Urinary Diversion

7.5 Bladder

7.6 Urethra

Male Reproductive Organs

CHAPTER 8

Principles of Assessment

8.2 Disfigurement

8.3 Scars and Skin Grafts

8.4 Contact Dermatitis

8.6 Skin Cancer

8.7 Criteria for Rating Permanent Impairment due to Skin Disorders

8.8 Skin Impairment Evaluation Summary

Principles of Assessment

Anemia

9.3 Myeloproliferative Disorders, including Polycythemia, Myelofibrosis, and Essential Thrombocytosis

9.4 White Blood Cell Diseases or Abnormalities .

9.5 Hemorrhagic and Platelet Disorders

9.6 Thrombotic Disorders

9.7 Criteria for Rating Permanent Impairment due to Lymphoma and Metastatic Disease

9.8 Hematologic Impairment Evaluation Summary

.191

.193

.201

.209

CHAPTER 10

10.1 Principles of Assessment

10.2 Hypothalamic-Pituitary Axis

10.3 Thyroid .

10.4 Parathyroids

10.5 Adrenal Cortex

10.6 Adrenal Medulla

10.7 Pancreas (Islets of Langerhans)

10.8 Gonads

10.9 Mammary Glands

10.10 Metabolic Bone Disease

10.11 Endocrine System Impairment Evaluation Summary

CHAPTER 11 Ear, Nose, Throat, and

11.3 The Face

11.4 The Nose, Throat, and Related Structures

CHAPTER 12

12.1 Principles of Assessment

Impairment of the Visual System

12.5 Visual Acuity Measurement at Near (Reading Acuity) .

12.6 Reporting Aids

.312

CHAPTER 13

13.1 Principles of Assessment . . .

13.2 Method for Rating Impairments due to Nervous System Disorders .

.326

13.3 Criteria for Rating Cerebral Impairments . . . .326

13.4 Criteria for Rating Impairment due to Spinal Cord Dysfunction and Movement Disorders

13.5 Criteria for Rating Impairments of the Upper Extremities due to CNS Dysfunction

13.6 Criteria for Rating Impairments of Station, Gait, and Movement Disorders .

13.7 Criteria for Rating Neurogenic Bowel, Bladder, and Sexual Dysfunction

13.8 Criteria for Rating Neurogenic Respiratory Dysfunction

13.9 Criteria for Rating Peripheral Neuropathies, Neuromuscular Junction Disorders, and Myopathies

13.10 Criteria for Rating Impairments Related to Complex Regional Pain Syndrome

13.11 Criteria for Rating Impairments Related to Craniocephalic Pain

13.12 Criteria for Rating Miscellaneous Peripheral Nerves of the Head and Trunk

13.13 Nervous System Impairment Evaluation Summary

.333

.335

.336

.336

.337

.339

.341

.343

Principles of Assessment

Psychiatric/Psychological Evaluation

14.3 Special Features of the Mental and Behavioral Disorders Independent Medical Examination.

14.4 Maximum Medical Improvement.

14.5 Concepts for Impairment Ratings .

14.6 Method of Impairment Rating.

14.7 Examples of Impairment Ratings due to Mental and Behavioral Disorders

14.8 Appendix: Brief Psychiatric Rating Scale . . . .369

CHAPTER

15 The Upper Extremities

15.1 Principles of Assessment

15.2 Diagnosis-Based Impairment

15.3 Adjustment Grid and Grade Modifiers: Non-Key Factors

15.4 Peripheral Nerve Impairment

15.5 Complex Regional Pain Syndrome Impairment .

15.6 Amputation Impairment

15.7 Range of Motion Impairment

15.8 Summary

15.9 Appendix 15-A: Functional Assessment Inventories .

Appendix 15-B: Electrodiagnostic Evaluation of Entrapment Syndromes.

CHAPTER

16

16.1 Principles of Assessment

16.2 Diagnosis-Based Impairment

16.3 Adjustment Grid and Grade Modifiers –Non-Key Factors

16.4 Peripheral Nerve Impairment

16.5 Complex Regional Pain Syndrome Impairment

16.6 Amputation Impairment

16.7 Range of Motion Impairment

16.8 Summary .

.387

.405

.419

.454

.459

.482

.487

CHAPTER 17

17.1 Principles of Assessment . .

17.2 Diagnosis-Based Impairment

17.3 Adjustment Grid and Grade Modifiers: Non-Key Factors .

17.4 Pelvic Impairment

17.5 Summary

17.6 Appendix 17-A: Pain Disability Questionnaire

APPENDIX

Appendix A: Combined Values Chart .

Appendix B: Burden of Treatment Scoring .

.558

.604

.607

GLOSSARY

INDEX

.494

.497

515

.531

.538

.542

.543

.550

16.9 Appendix 16-A: Lower Limb Questionnaire . .555

CHAPTER 1

Conceptual Foundations and Philosophy 1

Table 1-1 Self-Care

Table 1-2 Hierarchy of Study Types .

Table 1-3 ICF Codes and Functional Levels

Table 1-4 Sample Impairment Functional Classification

*Table 1-5 Generic Template for Impairment Classification Grids

Table 1-6 General Principles and Rules for Calculating Impairment

CHAPTER 2

Table 4-3 Energy Expenditure in METs During Bicycle Ergometry . . .

Table 4-4 Methodology for Determining the Grade in an Impairment Class . . .

.7

.8

.11

.11

.14

*Table 4-5 Criteria for Rating Permanent Impairment due to Valvular Heart Disease

*Table 4-6 Criteria for Rating Impairment due to Coronary Artery Disease

*Table 4-7 Criteria for Rating Impairment due to Cardiomyopathies

*Table 4-8 Criteria for Rating Impairment due to Pericardial Heart Disease

.49

.50

.53

.55

.59

.61

*Table 4-9 Criteria for Rating Permanent Impairment due to Dysrhythmias . . . .64

Table 4-10 Classification of Blood Pressure for Adults

Practical Application of the Guides 19

Table 2-1 Fundamental Principles of the Guides .

CHAPTER 3

.20

Pain-Related Impairment 31

*Table 3-1 Pain-Related Impairment and Whole Person Impairment Based on Pain Disability Questionnaire

CHAPTER 4 The Cardiovascular System

Table 4-1 NYHA Functional Classification of Cardiac Disease.

Table 4-2 Relationship of METs and Functional Class According to 5 Treadmill Protocols .

.66

*Table 4-11 Criteria for Rating Impairment due to Hypertensive Cardiovascular Disease

.67

*Table 4-12 Criteria for Rating Impairment due to Peripheral Vascular Disease – Lower Extremity

.69

*Table 4-13 Criteria for Rating Impairment due to Peripheral Vascular Disease – Upper Extremity

.70

*Table 4-14 Criteria for Rating Impairment due to Diseases of the Pulmonary Artery . . . .72

Table 4-15 Cardiac Impairment Evaluation Summary

CHAPTER 5

.74

.48

.49

The Pulmonary System 77

Table 5-1 Impairment Classification of Dyspnea (Adapted) .

Table 5-2 Impairment Classification for Prolonged Physical Work Intensity by Oxygen Consumption

.79

.85

Table 5-3 Methodology for Determining the Grade in an Impairment Class . . . . . . .86

*Table 5-4 Criteria for Rating Permanent Impairment due to Pulmonary Dysfunctiona

*Table 5-5 Criteria for Rating Permanent Impairment due to Asthma

Table 5-6 Scale for Judging Capabilities of Subjects With Cancer

Table 5-7 Pulmonary Impairment Evaluation Summary

CHAPTER 6

Digestive System

Table 6-1 Desirable Weights for Men by Height and Body Build

Table 6-2 Desirable Weights for Women by Height and Body Build

Table 6-3 Methodology for Determining the Grade in an Impairment Class . .

*Table 6-4 Criteria for Rating Permanent Impairment due to Upper Digestive Tract (Esophagus, Stomach and Duodenum, Small Intestine, and Pancreas) Disease

*Table 6-5 Criteria for Rating Permanent Impairment due to Colonic and Rectal Disorders

*Table 6-6 Criteria for Rating Permanent Impairment due to Anal Disease .

Table 6-7 Impairments From Surgically Created Stomas

*Table 6-8 Criteria for Rating Permanent Impairment due to Liver Disease

*Table 6-9 Criteria for Rating Permanent Impairment due to Biliary Tract Disease

*Table 6-10 Criteria for Rating Permanent Impairment due to Herniation .

Table 6-11 Digestive System Impairment Evaluation Summary

.88

.90

.92

.96

*Table 7-3 Criteria for Rating Permanent Impairment due to Urinary Diversion Disorders .

*Table 7-4 Criteria for Rating Permanent Impairment due to Bladder Disease

*Table 7-5 Criteria for Rating Permanent Impairment due to Urethral Disease .

.138

.139

.141

*Table 7-6 Criteria for Rating Permanent Impairment due to Penile Disease . . .144

*Table 7-7 Criteria for Rating Permanent Impairment due to Scrotal Disease

*Table 7-8 Criteria for Rating Impairment due to Testicular, Epididymal, and Spermatic Cord Disease

.146

.147

.104

.104

.105

.107

114

116

118

119

.120

.122

.124

CHAPTER 7

The Urinary and Reproductive Systems 129

Table 7-1 Methodology for Determining the Grade in an Impairment Class

*Table 7-2 Criteria for Rating Permanent Impairment due to Upper Urinary Tract Disease.

.130

.134

*Table 7-9 Criteria for Rating Impairment due to Prostate Disease

*Table 7-10 Criteria for Rating Permanent Impairment due to Vulval and Vaginal Disease

*Table 7-11 Criteria for Rating Permanent Impairment due to Cervical and Uterine Disease

*Table 7-12 Criteria for Rating Permanent Impairment due to Fallopian Tube and Ovarian Disease

Table 7-13 Urinary and Reproductive Systems Impairment Evaluation Summary

.149

.152

.154

CHAPTER 8

Table 8-1 Structure, Functions, and Disorders of the Skin

.160

*Table 8-2 Criteria for Rating Permanent Impairment due to Skin Disorders . . .166

Table 8-3 Skin Impairment Evaluation Summary

CHAPTER 9

Table 9-1 Karnofsky Performance Status Scale Definitions Rating (%) Criteria

Table 9-2 Eastern Cooperative Oncology Group Performance Status Scale (ECOG-PSS)

Table 9-3 Burden of Treatment Compliance . . .186

Table 9-4 Methodology for Determining the Grade in an Impairment Class . . . . . .187

*Table 9-5 Criteria for Rating Permanent Impairment due to Anemia .

.189

*Table 9-6 Criteria for Rating Permanent Impairment due to Neutropenia . . . .194

*Table 9-7 Criteria for Rating Permanent Impairment due to the Leukemias . . .196

*Table 9-8 Criteria for Rating Permanent Impairment due to HIV Disease . . . . .199

*Table 9-9 Criteria for Rating Impairment due to Platelet Disorders

*Table 9-10 Criteria for Rating Impairment due to the Hemophilias

*Table 9-11 Criteria for Rating Impairment due to Other Bleeding Disorders

*Table 9-12 Criteria for Rating Impairment due to Thrombotic Disorders

*Table 9-13 Criteria for Rating Impairment due to Lymphoma and Metastatic Disease

Table 9-14 Hematologic Impairment Evaluation Summary

.202

.204

.205

.208

.209

.210

CHAPTER 10

The Endocrine System

Table 10-1 Methodology for Determining the Grade in an Impairment Class

Table 10-2a Enteral, Intranasal, and Topical Medications

Table 10-2b Parenteral Medications

Table 10-3 Points Assigned for Dietary Modification

Table 10-4 Procedure-Based Points

*Table 10-5 Criteria for Rating Impairment due to Disorders of the HypothalamicPituitary Axis.

*Table 10-6 Criteria for Rating Impairment due to Thyroid Abnormalities.

*Table 10-7 Criteria for Rating Impairment due to Disorders of the Parathyroids

*Table 10-8 Criteria for Rating Impairment due to Disorders of the Adrenal Cortex

*Table 10-9 Criteria for Rating Impairment due to Disorders of the Adrenal Medulla

*Table 10-10 Criteria for Rating Impairment due to Diabetes Mellitus

*Table 10-11 Criteria for Rating Impairment due to Hypoglycemia

*Table 10-12 Criteria for Rating Impairment due to Gonadal Disorders

*Table 10-13 Criteria for Rating Impairment due to Mammary Disorders . .

.240

*Table 10-14 Criteria for Rating Impairment due to Metabolic Bone Disease . . . . . . . .242

Table 10-15 Endocrine System Impairment Evaluation Summary

CHAPTER 11

Ear, Nose, Throat, and Related Structures

Table 11-1 Monaural Hearing Loss and Impairment

Table 11-2 Computation of Binaural Hearing Impairment

Table 11-3 Relationship of Binaural Hearing Impairment to Impairment of the Whole Person

*Table 11-4 Criteria for Rating Impairments due to Vestibular Disorders . .

*Table 11-5 Criteria for Rating Impairment due to Facial Disorders and/or Disfigurement

*Table 11-6 Criteria for Rating Impairment due to Air Passage Deficits

.244

.215

.217

.217

.217

.218

.220

.223

.224

.227

.231

.234

.237

.239

*Table 11-7 Impairments of Mastication and Deglutition: Relationship of Dietary Restrictions to Permanent Impairment

*Table 11-8 Criteria for Rating Voice and Speech Impairment

247

.250

.252

.254

. .258

Table 12-1 Calculation Steps for the Visual System

*Table 12-2 Impairment of Visual Acuity .

Table 12-3 Calculation of the Acuity-Related Impairment Rating

*Table 12-4 Classification of Impairment of Visual Acuity

.267

.269

.274

.283

.288

.289

.290

Table 12-5 Impairment of the Visual Field . . . . .296

Table 12-6 Conversion of Field Radius to Field Score

Table 12-7 Calculation of the Visual Field–Related Impairment Rating

*Table 12-8 Classification of Impairment of Visual Field

.296

.297

.298

Table 12-9 Correction for Central Scotomata . . .304

*Table 12-10 Classification of Impairment of the Visual System and of the Whole Person

. .307

Table 12-11 Determination of Reading Acuity and Impairment Rating Using Letter Size and Viewing Distance .

.310

CHAPTER

13

The Central and Peripheral Nervous System 321

Table 13-1 Summary of Chapters Used to Rate Various Neurologic Disorders

Table 13-2 Activities of Daily Living

Table 13-3 Neurologic Impairments That are Combined With the Most Severe Cerebral Impairment

*Table 13-4 Criteria for Rating Impairment of Consciousness and Awareness . . .

*Table 13-5 Criteria for Rating Impairment due to Episodic Loss of Consciousness or Awareness

*Table 13-6 Criteria for Rating Impairment due to Sleep and Arousal Disorders .

Table 13-7 Mental Status Exam for the Neurologically Impaired Patient

*Table 13-8 Criteria for Rating Neurologic Impairment due to Alteration in Mental Status, Cognition, and Highest Integrative Function (MSCHIF)

*Table 13-9 Criteria for Rating Impairment due to Aphasia or Dysphasia

Table 13-10 Global Assessment of Functioning (GAF) Impairment Score

*Table 13-11 Criteria for Rating Impairments of the Upper Extremities due to CNS Dysfunction

*Table 13-12 Criteria for Rating Impairments due to Station and Gait Disorders

*Table 13-13 Criteria for Rating the Neurogenic Bowel

*Table 13-14 Criteria for Rating the Neurogenic Bladder

*Table 13-15 Criteria for Rating Neurogenic Sexual Dysfunction

*Table 13-16 Criteria for Rating Neurogenic Respiratory Dysfunction

Table 13-17 Dysesthetic Pain Secondary to Peripheral Neuropathy or Spinal Cord Injury

Table 13-18 Grading System for Rating Impairment due to Migraine Headache . .

.342

*Table 13-19 Criteria for Rating Trigeminal or Glossopharyngeal Neuralgia . . . . . . .343

*Table 13-20 Criteria for Rating Miscellaeous Peripheral Nerves

CHAPTER 14

.323

.323

.326

.327

.328

.329

.330

.344

.331

.332

.334

.335

.336

.337

.337

.338

.338

.339

Mental and Behavioral Disorders 347

Table 14-1 Multiaxial System of the DSM-IV-TR

Table 14-2 Mental Status Examination

Table 14-3 Selected Psychological Assessment Tools in Adults .

Table 14-4 Suggestions for the M&BD IME.

Table 14-5 Functional Impairment Scales for Patients With M&BD

Table 14-6 Factors That May Affect Motivation

Table 14-7 Characteristics Suggestive of Malingering

Table 14-8 BPRS Form

*Table 14-9 Impairment Score of Brief Psychiatric Rating Scale (BPRS)

*Table 14-10 Impairment Score of Global Assessment of Functioning Scale (GAF)

Table 14-11 Self-Care, Personal Hygiene, and Activities of Daily Living

Table 14-12 Role Functioning, Social and Recreational Activities

Table 14-13 Travel

Table 14-14 Interpersonal Relationships

Table 14-15 Concentration, Persistence, and Pace

Table 14-16 Resilience and Employability

*Table 14-17 Impairment Score of Psychiatric Impairment Rating Scale (PIRS)

CHAPTER 15

The Upper Extremities

Table 15-1 Definition of Impairment Classes .

*Table 15-2 Digit Regional Grid: Digit Impairments

*Table 15-3 Wrist Regional Grid: Upper Extremity Impairments

*Table 15-4 Elbow Regional Grid: Upper Extremity Impairments

.348

.349

.350

.352

.352

.353

.354

.358

.358

.359

.359

.359

.360

*Table 15-5 Shoulder Regional Grid: Upper Extremity Impairments .

Table 15-6 Adjustment Grid: Summary .

Table 15-7 Functional History Adjustment: Upper Extremities

Table 15-8 Physical Examination Adjustment: Upper Extremities

Table 15-9 Clinical Studies Adjustment: Upper Extremities

.401

.406

.406

.408

.410

*Table 15-10 Methodology for Determining the Grade in an Impairment Class . . . . . .412

Table 15-11 Impairment Values Calculated From Upper Extremity Impairment . . .

Table 15-12 Impairment Values Calculated From Digit Impairment .

Table 15-13 Monofilament Test Criteria

Table 15-14 Sensory and Motor Severity

Table 15-15 Sensory Quality Impairment

Classification

.420

.421

.424

.425

.426

Table 15-16 Digit Impairment for Transverse and Longitudinal Sensory Losses in Thumb and Little Finger Based on Percent of Digital Length Involved

.427

Table 15-17 Digit Impairment for Transverse and Longitudinal Sensory Losses in Index, Middle, and Ring Fingers

Table 15-18 Impairment for Sensory Only Peripheral Nerve Injury

.427

.429

Table 15-19 Origins and Functions of Peripheral Nerves of Upper Extremity Emanating From Brachial Plexus

*Table 15-20 Brachial Plexus Impairment: Upper Extremity Impairments

*Table 15-21 Peripheral Nerve Impairment: Upper Extremity Impairments

Table 15-22 Activities of Daily Living

*Table 15-23 Entrapment/Compression Neuropathy Impairment

*Table 15-24 Diagnostic Criteria for Complex Regional Pain Syndrome

*Table 15-25 Objective Diagnostic Criteria Points for Complex Regional Pain Syndrome

*Table 15-26 Complex Regional Pain Syndrome (Type I): Upper Extremity Impairments

Table 15-27 Level of Amputation

*Table 15-28 Impairment for Upper Limb Amputation at Various Levels .

*Table 15-29 Amputation Impairment

*Table 15-30 Thumb Range of Motion

*Table 15-31 Finger Range of Motion

*Table 15-32 Wrist Range of Motion .

*Table 15-33 Elbow/Forearm Range of Motion . . .474

*Table 15-34 Shoulder Range of Motion .

.475

*Table 15-35 Range of Motion Grade Modifiers . .477

*Table 15-36 Functional History Grade Adjustment: Range of Motion. . . . . .477

Table 15-37 Activities of Daily Living Questionnaire

.431

.434

.436

.445

.449

.453

.453

.454

.456

.457

.460

.468

.470

.473

.483

Table 15-38 ADLs Questionnaire Evaluation . . . . .484

Table 15-39 Comparison Between Quick DASH and ADL Questionnaires . . . . . . . . . .485

Table 15-40 Self-Report Functional Assessment Measures

.486

CHAPTER 16

The Lower Extremities

493

Table 16-1 Definition of Impairment Classes . . . .495

*Table 16-2 Foot and Ankle Regional Grid –Lower Extremity Impairments .

*Table 16-3 Knee Regional Grid – Lower Extremity Impairments

*Table 16-4 Hip Regional Grid – Lower Extremity Impairments

Table 16-5 Adjustment Grid: Summary .

Table 16-6 Functional History Adjustment –Lower Extremities

Table 16-7 Physical Examination Adjustment –Lower Extremities

Table 16-8 Clinical Studies Adjustment – Lower Extremities

*Table 16-9 Methodology for Determining the Grade in an Impairment Class

*Table 16-10 Impairment Values Calculated From Lower Extremity Impairment

Table 16-11 Sensory and Motor Severity

*Table 16-12 Peripheral Nerve Impairment –Lower Extremity Impairments .

*Table 16-13 Diagnostic Criteria for Complex Regional Pain Syndrome

*Table 16-14 Objective Diagnostic Criteria Points for Complex Regional Pain Syndrome

*Table 16-15 Complex Regional Pain Syndrome (Type 1) – Lower Extremity Impairments

*Table 16-16 Amputation Impairment

.501

.509

512

515

.516

517

.519

.520

.530

.533

.534

.539

.540

.541

.542

Table 16-17 Functional History Net Modifier . . . .545

*Table 16-18 Lesser Toe Impairments.

*Table 16-19 Greater Toe Impairments

*Table 16-20 Hindfoot Motion Impairments.

.549

.549

.549

*Table 16-21 Ankle or Hindfoot Deformity Impairments

.549

*Table 16-22 Ankle Motion Impairments . . . . . . . .549

*Table 16-23 Knee Motion Impairments .

*Table 16-24 Hip Motion Impairments – Lower Extremity Impairment

*Table 16-25 Range of Motion ICF Classification . .

CHAPTER 17

.549

.549

.550

*Table 17-4 Lumbar Spine Regional Grid: Spine Impairments . . . . . . . . . . . . . .570

Table 17-5 Adjustment Grid: Summary . .

Table 17-6 Functional History Adjustment: Spine

Table 17-7 Physical Examination Adjustment: Spine

The Spine and Pelvis 557

Table 17-1 Definition of Impairment Classes and Impairment Ranges . . .

*Table 17-2 Cervical Spine Regional Grid: Spine Impairments

*Table 17-3 Thoracic Spine Regional Grid: Spine Impairments

* Indicates Impairment Rating Table

.559

.564

.567

.575

.575

.576

Table 17-8 Common Radicular Syndromes . . . . .578

Table 17-9 Clinical Studies Adjustment: Spine . .581

*Table 17-10 Methodology for Determining the Grade in an Impairment Class . . . . . .582

*Table 17-11 Diagnosis-Based Impairment Grid: Pelvis

*Table 17-12 Functional History Adjustment: Pelvis

*Table 17-13 Physical Examination Adjustment: Pelvis . .

.593

.594

.595

*Table 17-14 Clinical Studies Adjustment: Pelvis. . .595

*Table 17-A PDQ Scoring .

.599

Illustrations

CHAPTER 1

Conceptual Foundations and

Figure 1-1 ICF Model of Disablement.

.3

Figure 1-2 World Health Organization’s International Classification of Illness . . .4

CHAPTER 2

Practical Application of the Guides 19

Figure 2-1 Hierarchy in Whole Person Concept for Upper and Lower Extremities.

Figure 2-2 Hierarchy in Whole Person Concept for Upper Extremity and Hand

Figure 2-3 Sample Report for Permanent Medical Impairment

CHAPTER 3

Figure 3-1 Nociception

CHAPTER 12

Visual System

Figure 12-1 Distribution of the Grid Points for Visual Field Evaluation

Figure 12-2 Normal Visual Field

Figure 12-3 Midperipheral Scotoma

Figure 12-4 Juxtafoveal Scotoma

Figure 12-5 Tunnel Vision: Automated Perimetry Plot

.22

.22

Figure 12-6 Effect of Nasal Field Loss on the Binocular Field .

Figure 12-7 Effect of Temporal Field Loss on the Binocular Field

Figure 12-8 Conversion From VSI to WPI .

Figure 12-9 Evaluation of Permanent Visual Impairment

.302

.303

.307

.313

Figure 12-10 Overlay Grid for Goldmann Fields . . .315

Figure 12-11 Overlay Grids for Humphrey Field Plots

CHAPTER 15

The Upper Extremities

Figure 15-1 Upper Extremity Regions

Figure 15-2 Upper Extremity Impairment Evaluation

Figure 15-3 Techniques for Measuring the Scaphoid, Lunate Axis, and Long Axis of the Radius and Corresponding Angles .

Figure 15-4 Digit Impairment due to Thumb Amputation at Various Lengths or Total Transverse Sensory Loss . .

.409

.426

Figure 15-5 Digit Impairment due to Finger Amputation at Various Lengths or Total Transverse Sensory Loss . . . . . .426

Figure 15-6 Hand Impairment Values for Total Transverse Sensory Loss and Total Longitudinal Sensory Loss on Radial and Ulnar Sides Involving 100 % of the Digit Length.

Figure 15-7 Motor Innervation of the Upper Extremity

Figure 15-8 Cutaneous Innervation of the Upper Extremity and Related Peripheral Nerves and Roots

. .428

.432

.432

Figure 15-9 Impairment Estimates for Upper Extremity Amputation at Various Levels

Figure 15-10 Impairments of the Digits and the Hand for Amputation at Various Levels

Figure 15-11 Digit Impairment Percent for Thumb Amputation at Various Levels

.456

.456

.458

Figure 15-12 Digit Impairment Percent for Finger Amputation at Various Levels . . . . . .458

Figure 15-13 Upper Extremity Range of Motion Record

Figure 15-14 Measurement of MCP Joint Position in Flexion, Extension Lag, Full Extension, and Hyperextension . .

Figure 15-15 Neutral Position and Flexion of Thumb IP Joint

.462

. .466

.467

Figure 15-16 Flexion of Thumb MCP Joint . . . . . . .467

Figure 15-17 Neutral Position of Thumb MCP Joint

.467

Figure 15-18 Thumb Radial Abduction, Measuring the Angle of Separation Formed Between First and Second Metacarpals in Coronal Plane . . . . . .467

Figure 15-19 Adduction of Thumb

Figure 15-20 Linear Measurements of Thumb Opposition (cm) at Various Positions

Figure 15-21 Neutral Position and Flexion of Finger DIP Joint

Figure 15-22 Neutral Position and Flexion of Finger PIP Joint

Figure 15-23 Neutral Position and Flexion of Finger MCP Joint.

Figure 15-24 Wrist Flexion and Extension

Figure 15-25 Radial Deviation and Ulnar Deviation of the Right Wrist

Figure 15-26 Flexion and Extension of Elbow

Figure 15-27 Pronation and Supination of Forearm

Figure 15-28 Shoulder Flexion and Extension.

Figure 15-29 Shoulder Abduction and Adduction

Figure 15-30 Shoulder External Rotation and Internal Rotation

Figure 15-31 Upper Extremity Impairment Evaluation Example .

.467

.467

.470

.470

.471

.472

.473

.474

.475

.475

.476

.476

.480

CHAPTER 16

The Lower Extremities 493

Figure 16-1 Lower Extremity Regions.

Figure 16-2 Lower Extremity Impairment Evaluation Record .

Figure 16-3 Sensory Nerves of the Lower Extremity . .

Figure 16-4 Motor Nerves of the Lower Extremity

Figure 16-5 Evaluating the Range of Motion of a Toe: The Metatarsophalangeal (MTP) Joint of the Great Toe

.494

.498

.537

.537

.545

Figure 16-6 Measuring Inversion and Eversion . . .546

Figure 16-7 Measuring Ankle Dorsiflexion (Extension) and Plantar Flexion

Figure 16-8 Measuring Knee Flexion

Figure 16-9 Using a Goniometer to Measure Flexion of the Right Hip

Figure 16-10 Neutral Position, Abduction, and Adduction of Right Hip

Figure 16-11 Measuring Internal and External Hip Rotation

Figure 16-12 Lower Extremity Range of Motion Record

Figure 16-13 Lower Extremity Impairment Evaluation Record Example .

.546

.546

.547

.547

.548

.551

.554

CHAPTER 17

The Spine and Pelvis

Figure 17-1 Spine and Pelvis Regions

Figure 17-2 Spine and Pelvis Impairment Evaluation Record

Figure 17-3 Skin Areas Innervated by Cervical and Thoracic Nerve Roots Showing Autonomous Zones

Figure 17-4 Skin Areas Innervated by Thoracic and Lumbosacral Nerve Roots and Showing Autonomous Zones

Figure 17-5 Loss of Motion Segment Integrity, Translation

Figure 17-6 Loss of Motion Segment Integrity, Angular Motion (Sagittal Rotation), Lumbar Spine

Figure 17-7 Spine and Pelvis Evaluation Record Example

Figure 17-A Pain Disability Questionnaire

.558

.561

.577

.578

.579

.580

.598

.600

Conceptual Foundations and Philosophy

1.1 History of the Guides

1.2 New Directions for the Sixth Edition

1.3 The International Classification of Functioning, Disability, and Health (ICF): A Contemporary Model of Disablement

1.4 Measurement Issues

1.5 Balancing Science and Clinical Judgment

1.6 The Case for Simplification and Ease of Application

1.7 The Application of Functional Assessment

1.8 The Need for Internal Consistency and a Uniform Template

1.9 Summary

1.1 History of the Guides

Tolerance of and care for the sick and the disabled may be elemental components of our social fabric rooted in the very origins of human society. Anthropological evidence supports the notion that our earliest ancestors were afforded communal benefits in terms of improved odds of survival of hereditary and physical impairments that might otherwise prove fatal to the individual.1 The concept of compensation for personal injuries and resulting disabilities is hardly a contemporary one; historical evidence documents that social justice and compensation systems for injured parties have been around since recorded history.1,2

Since antiquity, from ancient Babylonian societies 4000 years ago to the Roman Empire many centuries later, lawgivers attempted to legislate justice in moral, social and economic spheres, which inter alia provided for pecuniary compensation.3 These various attempts to legislate monetary compensation for personal injuries were aimed at ridding the society of the blood feud and replacing it with a more civilized and enlightened system involving the exchange of monetary value for losses resulting from personal injuries. For example, the Lombard laws 2 millennia

ago set forth monetary compensation values for all sorts of injuries, from minor loss such as teeth to the loss of eye and limbs. These systems even accounted for cosmetic loss, doubling the value of a lost tooth if it showed on smile.4 Such monetary compensation schemes, in terms of their whole person values, are strikingly similar to some of our contemporary systems of compensation for disablement.

The Guides reflects experience with impairment ratings over the centuries1,2 and started in 1958 with publication by the American Medical Association (AMA) of the article, A Guide to the Evaluation of Permanent Impairment of the Extremities and Back.5 Over the next 12 years, 12 additional guides appeared in JAMA, and in 1971 a compendium of these 13 guides became the First Edition of the Guides.6

The Guides is revised periodically to incorporate current scientific clinical knowledge and judgment. For example, the Third Edition, published in 1988, introduced pie charts for range of motion (ROM) impairment evaluation of the upper extremities.7 In 1993 the Fourth Edition introduced the DiagnosisRelated Estimates (DRE) or “injury” model to the evaluation of spinal injuries.8 A pain chapter was introduced in the Fourth Edition and refined in the Fifth Edition in 2000.9 The Fifth Edition modified the DRE method and expanded the ROM method for spinal impairment evaluations. The Sixth Edition represents this continued evolution and introduces a “paradigm shift” to the assessment of impairment.

1.2 New Directions for the Sixth Edition

1.2a Previous Criticisms of the Guides

The Guides is revised to reflect the latest scientific research and evolving medical evidence. Earlier versions of the Guides were subject to criticisms,10–17 which included the following:

• There was a failure to provide a comprehensive, valid, reliable, unbiased, and evidence-based rating system.

• Impairment ratings did not adequately or accurately reflect loss of function.

• Numerical ratings were more the representation of “legal fiction than medical reality.”17

Recommended changes included:

• Standardized assessment of Activities of Daily Living (ADL) limitations associated with physical impairments.

• Application of functional assessment tools to validate impairment rating scales.

• Include measures of functional loss in the impairment rating.

• Overall improvements in intrarater and interrater reliability and internal consistency.14

Although attempts were made to correct these deficiencies in the Fifth Edition, problems persisted. These were attributable, in part, to adherence to antiquated and confusing terminology, limited validity and reliability of the ratings, lack of meaningful and consistent application of functional assessment tools, and lack of internal consistency.14 A high error rate among all ratings has been reported.18 In this edition there is a paradigm shift, which adopts a contemporary model of disablement; it is simplified, functionally based, and internally consistent to the fullest extent possible.

1.2b Five New Axioms of the Sixth Edition

The vision embodied by this paradigm shift is articulated in terms of 5 specific new axioms. These axioms provide direction and define priorities:

1. The Guides adopts the terminology and conceptual framework of disablement as put forward by the International Classification of Functioning, Disability, and Health (ICF).19

2. The Guides becomes more diagnosis based with these diagnoses being evidence-based when possible.

3. Simplicity, ease-of-application, and following precedent, where applicable, are given high priority, with the goal of optimizing interrater and intrarater reliability.

4. Rating percentages derived according to the Guides are functionally based, to the fullest practical extent possible.

5. The Guides stresses conceptual and methodological congruity within and between organ system ratings.

1.3 The International Classification of Functioning, Disability, and Health (ICF): A Contemporary Model of Disablement

1.3a

ICF Model

The World Health Organization (WHO) developed a comprehensive model of disablement, the International Classification of Functioning, Disability, and Health (ICF)19; this classification is depicted in Figure 1-1. The ICF framework is intended for describing and measuring health and disability at the individual and population levels. It consists of 3 key components:

1. Body functions and body structures: physiological functions and body parts, respectively; these can vary from the normal state, in terms of loss or deviations, which are referred to as impairments.

2. Activity: task execution by the individual and activity limitations are difficulties the individual may experience carrying out such activities.

3. Participation: involvement in life situations and participation restrictions are barriers to experiencing such involvement.

These components comprise functioning and disability in the model. In turn, they are related interactively to an individual with a given health condition, disorder, or disease, and to environmental factors and personal factors of each specific case.19

1.3b Applications of ICF Model to the Guides

Advantages

of ICF Model

The ICF model appears to be the best model for the Guides. It acknowledges the complex and dynamic interactions between an individual with a given health condition, the environment, and personal factors. The relationships between impairment, activity limitations, and participation are not assumed to be linear or unidirectional. An individual may experience measurable impairment without significant activity limitations that do not produce restrictions to major life activities such as work or recreation. On the other hand, one can experience significant activity limitations and/or participation restrictions in the absence of demonstrable impairment.

ICF Model of Disablement

FIGURE 1-1

History of Models of Disablement

The traditional model of disablement was based on the International Classification of Impairments, Disabilities, and Handicaps (ICIDH) that the WHO presented more than a quarter century ago.20 This model, depicted in Figure 1-2, focuses on the individual and extends across 4 levels of disablement in linear fashion. The first level, pathology (a disease or trauma at the tissue level), is viewed as giving rise to impairment (an abnormality in anatomic or physiological structure or function at the organ system level). This, in turn, gives rise to disability (the functional consequences to the individual in terms of abilities lost) within one’s personal sphere (ie, mobility; Activities of Daily Living, or ADLs); and eventually to handicap (a disadvantage to a given individual in terms of role fulfillment) in their societal sphere (may include barriers or impediments to functioning in a major life activity, such as work).14

The ICIDH model is overly simplistic and unidirectional. This unidirectional depiction of the relationships among impairments, disabilities, and handicaps implies causation and irreversibility; disabilities and handicaps can also give rise to impairments. The ICIDH model also lacks sufficient complexity to fully account for important environmental modifiers of a biological, psychological, and social nature.15 For example, the societal consequences of impairment may be substantially mitigated by environmental accommodations such as those mandated by the Americans with Disabilities Act,21 and by greater acceptance and enabling expectations.

Interim Developments of the WHO and Institute of Medicine

Saad Nagi22 developed a conceptual model of disablement in the 1960s that was similar to the WHO model. It recognized that the correlations among impairments, functional limitations, and associated disabilities were poor. He suggested that environmental factors were important modifiers of this relationship, albeit in a unidirectional sense.

In 1991 the Institute of Medicine (IOM) defined disability as “a function of the interaction of the person with the environment” and produced an interactive model of the “enabling-disabling process,” which identified 3 independent modifiers, including biology (ie, heredity), environment (ie, physical, social, psychological), and lifestyle and behavior.23

In 1997, a second International Classification of Impairments, Disabilities, and Handicaps (ICIDH-2) was presented by the WHO. 24 This model changed terminology of disablement (referencing impairments, disability, and handicap) to that of enablement (referencing impairments, activities, and participations). It provided unified and standard language to characterize the functional consequences of a variety of health conditions.24

FIGURE 1-2

World Health Organization’s International Classification of Illness

PathologyImpairment Disability Handicap

The underlying disease or diagnosis

The immediate physiological consequences, symptoms, and signs

The functional consequences, abilities lost

The social and societal consequences, freedoms lost

Rondinelli RD, Duncan PW. The concepts of impairment and disability. In Rondinelli RD, Katz RT, eds. Impairment Rating and Disability Evaluation. Philadelphia, Pa: WB Saunders Co; 2000:19. Used with permission.

The ICF recognizes that limitations to participation may secondarily produce activity restrictions or impairments. It also recognizes the impact of environmental and personal factors to the consequences of disease. Activity limitations and participation restrictions are not static. They may vary over time and be influenced by numerous physical and psychological factors that may also vary over time.

The ICF model is designed to be enabling in its approach and etiologically neutral in addressing human functioning as well as disability. It is inclusive in dealing with personal and environmental determinants of health and disablement, and is causally interactive as opposed to linearly predictive of its constructs and associations.

International Appeal and Applications

The ICF was developed out of a worldwide consensus process, which embodies broad cultural values and perspectives. The ICF model (unlike its predecessor, the ICIDH) was endorsed by the World Health Assembly in May 200125 and is now a member of the WHO Family of International Classifications. This acceptance reflects the increasing worldwide importance placed on recognition and reduction of burden of care associated with health conditions.

1.3c ICF Terminology and Definitions

According to the ICF, the following terms and definitions apply:

• Body functions: physiological functions of body systems (including psychological functions).

• Body structures: anatomic parts of the body such as organs, limbs, and their components.

• Activity: execution of a task or action by an individual.

• Participation: involvement in a life situation.

• Impairments: problems in body function or structure such as a significant deviation or loss.

• Activity limitations: difficulties an individual may have in executing activities.

• Participation restrictions: problems an individual may experience in involvement in life situations.

1.3d Operational Definitions: Impairment, Disability, Handicap

For purposes of the Guides, the following operational definitions and disclaimer apply:

Impairment: a significant deviation, loss, or loss of use of any body structure or body function in an individual with a health condition, disorder, or disease.

Disability: activity limitations and/or participation restrictions in an individual with a health condition, disorder, or disease.

Impairment rating enables the physician to render a quantitative estimate of losses to the individual as a result of their health condition, disorder, or disease. Impairment ratings are defined by anatomic, structural, functional, and diagnostic criteria; physicians are generally familiar with these criteria, based on their broader training and clinical experience. These ratings are determined by following accepted diagnostic processes and procedures. Most physicians are not trained in assessing the full array of human functional activities and participations that are required for comprehensive disability determinations. Impairment rating is a physician-driven first approximation of a process that attempts to link impairment with a quantitative estimate of functional losses in one’s personal sphere of activity. As a result, the following operational definition will continue to apply:

Impairment rating: consensus-derived percentage estimate of loss of activity reflecting severity for a given health condition, and the degree of associated limitations in terms of ADLs.

There are important remaining differences between the ICF and Guides terminology. The ICF model depicts only an association between body function/ structure, activity, participation, and a given health condition. Typically, in assessing impairment, the physician must determine if the health condition is causally related to an event or exposure.

The relationship between impairment and disability remains both complex and difficult, if not impossible, to predict. In some conditions there is a strong association between level of injury and the degree of functional loss expected in one’s personal sphere of activity (mobility and ADLs). The same level of injury is in no way predictive of an affected individual’s ability to participate in major life functions (including work) when appropriate motivation, technology, and

sufficient accommodations are available. Disability may be influenced by physical, psychological, and psychosocial factors that can change over time.

The Guides is not intended to be used for direct estimates of work participation restrictions. Impairment percentages derived according to the Guides’ criteria do not directly measure work participation restrictions. The intent of the Guides is to develop standardized impairment ratings to be used as follows:

1. Fix the diagnosis and associated percentage of physical and functional loss at “Maximum Medical Improvement” (MMI) (see Chapter 2).

2. Enable a patient with an impairment rating to exit from a system of temporary disablement (eg, temporary total or partial disablement under workers’ compensation before MMI).

3. Provide diagnosis and taxonomic classification of impairment as a segue into other systems of longterm disablement.

In disability evaluation, the impairment rating is one of several determinants of disablement. Impairment rating is the determinant most amenable to physician assessment; it must be further integrated with contextual information typically provided by nonphysician sources regarding psychological, social, vocational, and avocational issues.

1.3e Domains of Personal Function

There are 2 domains of human personal function that are most often affected by impairments and for which well-accepted measurement tools exist, and hence they are of particular interest to the impairment rater. These are mobility and “self-care,” which can be further defined and categorized as follows.26

Mobility

Transfer: movement of one’s body position while remaining at the same point in space (eg, supine to side lying, supine to sit, sit to stand).

Ambulation: movement of one’s body from one point in space to another (eg, walking, stair climbing, wheelchair locomotion).

Self-Care

Activities of Daily Living (ADLs): basic self-care activities performed in one’s personal sphere (eg, feeding, bathing, hygiene, dressing; see Table 1-1).

Instrumental Activities of Daily Living (IADLs): complex self-care activities (eg, financial management, medications, meal preparation), which may be delegated to others (see Table 1-1).

Examples of Impairment and Disability

Christopher Reeve was a well known celebrity who suffered a traumatic spinal cord injury resulting in a high-level cervical tetraplegia, a condition that would have an unusually high expected impairment rating due to the nearcomplete activity limitations that typically accompany it. In his particular case, he required elaborate mobility and ventilatory assistive equipment and the 24-hour availability of a personal care attendant to assist with virtually all selfcare activities. However, Mr. Reeve was highly exceptional in terms of his public persona and renown, and his access to significant personal financial assets and other resources. He was able to martial these constructively to create an education and research foundation for which he was the principal spokesperson, and to become globally recognized as a prime advocate for the spinal cord injured and disabled. His vocational success would be judged exceptional even for any ablebodied individual, and underscores the fact that participation restrictions do not correlate with activity limitations in many instances.

Similarly, a given physical impairment can be highly disabling in one vocational context and virtually non-disabling in another. For example, amputation of one’s great toe might preclude the vocation of a ballerina who must dance “on point,” whereas the same amputation might be of no functional consequence to a construction worker equipped with an appropriately fitted work boot.

These mobility and self-care activities may be performed independently (without the use of a helper or adaptive aids) or modified independently (require the use of adaptive aids but no helper), or they may require helper assistance with or without adaptive aids. The highest level of independence with which the given activity is consistently and safely carried out at the individual’s baseline is considered the functional level for that individual.27

1.4 Measurement Issues

Measurement issues are important determinants in defining impairment. The process of impairment rating relies on criteria that may be discrete (ie, amputation of a limb) or continuous (ie, loss of range

TABLE 1-1

Self-Care

Activities of Daily Living (ADLs)

Bathing, showering

Bowel and bladder management

Dressing

Eating

Feeding

Functional mobility

Personal device care

Personal hygiene and grooming

Sexual activity

Sleep/rest

Toilet hygiene

Instrumental Activities of Daily Living (IADLs)

Care of others (including selecting and supervising

caregivers)

Care of pets

Child rearing

Communication device use

Community mobility

Financial management

Health management and maintenance

Home establishment and maintenance

Meal preparation and cleanup

Safety procedures and emergency responses

Shopping

Source: Youngstrom. 26

of motion). Severity of an impairment also can vary according to discrete (ie, level of amputation) or continuous (ie, degrees of motion lost) criteria. There are 4 levels of measurement whereby test results can be analyzed and interpreted, including nominal, ordinal, interval, and ratio.28 Nominal and ordinal scales are used to classify discrete measures because the scores they produce occupy mutually exclusive categories. Interval and ratio scales apply to continuous measures because the scores produced occupy points on a continuum within an available range of scores.12

Precision, accuracy, reliability, and validity are critical issues in defining impairment. Precision refers to the smallest unit of change that a measurement instrument can distinguish. Sensitivity to change is critical to the measurement of the clinical effects of treatment, and the sensitivity of a measurement scale should be appropriate to the level of precision required in a given case. Reliability is the extent to which a measurement provides consistent information.

Measurement Scales

Nominal scales categorize items into different, internally equivalent groups based on a single criterion. They may be dichotomous (ie, 1 of 2 possible groups such as male vs female) or nondichotomous (ie, the colors of the spectrum). Ordinal scales categorize items hierarchically, based on order of magnitude, where intervals between groups are not assumed to be equal and the order of magnitude may differ for each group. Ordinal scales are most commonly used in clinical practice and are typical of the self-report functional outcome scales being adopted here. Interval scales, by contrast, are continuous scales, which are rank ordered according to uniform and sequential units of increment (ie, temperature scale). Ratio scales are interval scales whose zero point reflects absence of the quantity being measured.12

Analysis of nominal and ordinal data requires special considerations to avoid mistaken inference of the results.29,30 Controversy surrounds summation and averaging of subtest scores to produce an overall result for comparative purposes. As such, continuous-scale measures lend themselves more readily to rigorous statistical analysis than is possible for discrete counterparts.12 Since the comparative data being drawn upon for some organ systems of the Guides remain largely discrete, by nature, and have not been subjected to appropriate Rasch analysis or other manipulations, the use of normative statistics (eg, means, standard deviations) for comparative purposes in such cases remains problematic and will be avoided.

Validity is the extent to which an instrument measures that which it is intended to measure.

Previous work examining the validity of musculoskeletal impairments derived according to the Guides has yielded equivocal results.15,32,33 One study33 examined the validity of hand impairments due to loss of ROM or to amputation, and in terms of correlations of impairment ratings and objective measures of hand function. Approximately two thirds of the correlations were significant; hence, these results were touted as a validation of impairment ratings. However, the R2 coefficients derived from these correlations (amount of variance actually “explained” in terms of these correlations and regressions) were quite low (exceeded .5 in only 8% of correlations.) Another similar

Precision and Accuracy

Consideration must be given to feasibility and practicality of achieving a given level of precision, including cost and availability of equipment, and time required and ease of application in the field. For example, a Thomas test can rapidly reveal presence of a hip flexion contracture to an examiner but is less precise than standard goniometric assessment of ROM for impairment rating purposes. The term accuracy defines the ability of a measurement to correctly (and precisely) assess the condition or process being measured. The ability to do so depends on minimizing sources of error, which in human performance measurement include examiner training and skills required to use, the interface between subject and measurement device, and the instrument itself. Generally speaking, examiner training is usually the most variable.31

study32 showed significant correlations between lower extremity impairments associated with fractures and measures of functional performance as well as limitations measured on the Sickness Impact Profile (SIP). Again, these results were used to tout validity. However, the associated R2 coefficients were again quite small (R2 .32 and .30, respectively).

A more recent study15 estimated upper extremity impairments due to a simulated “fusion” at the metacarpophalangeal joint of the dominant extremity in otherwise healthy adult subjects, using individually fabricated hand splints. They examined randomized, real-time performance on standardized measures of hand function with and without the splints, to obtain correlations and regressions of impairment ratings and functional performance. Although simulated impairments in that study led to slowing of performance on all functional measures, the correlations of degree of slowing and magnitude of impairment were not significant. The methodological limitations and small number of these studies preclude definitive conclusions concerning validity of impairment ratings at this time.

Collectively, these studies do suggest that the criterion validity of musculoskeletal impairment ratings, as traditionally determined, remains limited. What this means is that functional losses (in terms of ADLs) associated with impairment are not being captured by (and reflected in) the impairment ratings themselves. Likewise, such validity as is possible to achieve in impairment ratings can be expected to improve if greater attention is paid to direct

measurement of functional losses in terms of ADLs, in the derivation of these ratings.

1.5 Balancing Science and Clinical Judgment

1.5a The Relative Merits of Study Designs

The relative merits of research study designs have been examined, and hierarchies of evidence have been proposed.34–36 The Agency for Health Care Policy and Research has adopted a hierarchy of study types,37 based on ability of study design to minimize the possibility of bias and confounding influence, as listed in Table 1-2.35 Strength of evidence is based largely on reliability estimates of study design.35 Steps for determining levels of evidence and grades of recommendations for evidence-based clinical guidelines are as follows:

• Levels of evidence are defined and ranked hierarchically based on study design (see Table 1-2) and methodological quality of individual studies.

• Questions to be addressed are carefully defined.

• Eligible evidence is defined, as are inclusion and exclusion criteria.

• All studies meeting the aforementioned criteria relating to a specific question are obtained using clearly defined search strategies.

• Eligible studies are summarized in an evidence table.

• The strength of evidence to support a given intervention or hypothesis is stated.

• Judgments regarding the consistency, generalizability, applicability, and overall clinical impact are considered in linking evidence to clinical recommendations.

TABLE 1-2

Hierarchy

of Study Types

Systematic reviews and meta-analyses of randomized controlled trials

Randomized controlled trials

Nonrandomized intervention studies

Observational studies

Nonexperimental studies

Expert opinion

• Grades of recommendations are based on strength of supporting evidence as modulated by the judgment of guideline developers, especially in the absence of evidence.

Historically, the numerical ratings applied for organ system impairment and whole person impairment throughout the Guides are based largely on consensus and expert opinion. Research has focused on reliability and reproducibility of ratings17 and functional validity of ratings.15,32,33 The evidence basis for impairment percentages assignable to ICF functional levels must await further empirical testing;19 infrastructure exists to develop such studies based on the ICF model, core sets, and ADL assessments.38,39

Impairment and disability are complex concepts that are not yet amenable to evidence-based definition. Diagnoses should be evidence-based, however, the impact of injury or illness is dependent on factors beyond physical and psychological aspects, including psychosocial, behavioral and contextual issues. Therefore, it is more challenging to obtain data needed to define an evidence-based approach to impairment assessment.

Given the dearth of higher-level, evidence-based criteria on which to base impairment ratings, the following approach was followed for this edition of the Guides:

1. Current literature was consulted to ensure evidence-based approach for diagnoses used to determine consensus based impairment ratings.

2. Where ratings must be consensus based, due to absence or lack of valid objective data, explanation of the specific basis on which the ratings are derived is provided. Normative judgments that are not data driven will follow precedent in many cases and must await future validation studies before significant change is adopted.

3. Attempts have been made to normalize impairment ratings across organ systems to improve internal consistency. Decisions, in such cases, are

Reliability

A simple conceptualization of reliability is to consider a gun as a measurement instrument, and the shots fired at a target as the measurements themselves. If the shots cluster tightly, the gun is shooting with high reliability, regardless of where the cluster appears on the target. If the shots fail to cluster, the reliability is low.12 Reliability can vary significantly between instruments for a given rater, and between raters for a given instrument.40

Validity

Using the target analogy, if a gun (instrument) is aimed at the target, validity is the ability to hit the target at the point being aimed at. For purposes of discussion here, impairment ratings can be considered in terms of their content validity, construct validity, and criterion validity. Content validity of a particular test refers to its ability to cover a representative sample of a particular domain being measured. For example, “hand impairment” is determined by examining digital amputation level, joint ROM, sensory loss, and/or other anatomic and functional aspects of the hand. Such validity is generally asserted by expert opinion (Delphi panel). Construct validity refers to the extent to which the test measures some theoretical construct such as functioning (eg, ADLs), pain, or suffering. Criterion validity refers to whether or not the test measure in question correlates well (is predictive) with some independent criterion or “gold standard.” For example, a contrast venogram is a highly accurate test for detecting deep venous thrombosis (DVT). A venous Doppler is a less invasive and less costly alternative, which has shown high criterion validity to a venogram and, hence, is typically used instead to make the diagnosis of DVT in the clinical setting.12

consensus based and will remain so until future validation studies can be carried out.

1.6 The Case for Simplification and Ease of Application

The consensus of the Guides’ editors is that simplification and brevity, in conjunction with greater clarity, are needed. When evidence-based criteria are lacking, priorities for simplification apply.

1.7 The Application of Functional Assessment

1.7a Earlier Approaches That Have Worked Well

Criticism of previous editions of the Guides includes lack of validity due, in part, to inadequate attention to functional assessment.13,15,17 Historically, attention

to functional (as opposed to anatomic) loss in impairment rating determinations has varied by organ system and the availability of functional data. In the cardiovascular system, for example, anatomic loss refers to damage to an organ or body system (eg, left ventricular hypertrophy), whereas functional loss includes loss such as decreased ejection fraction of the heart. The New York Heart Association41 also provides a well-accepted 4-class, functionally based scheme (NYHA classes I-IV) according to symptoms with activity and overall functional ability in terms of ADLs. There is good evidencebased research linking the NYHA functional class to clinical status (activity tolerance) and metabolic equivalents (METs) achievable on treadmill testing.42 Similarly, in the respiratory system, a functionally based classification of dyspnea in relation to ADLs43 has been applied, and impairment ratings have been developed based on results of pulmonary function testing as well as exercise test results. The ADL-based functional assessment needs to be incorporated into the neurologic, musculoskeletal, and other organ systems of the Guides.

1.7b Self-Report Assessment Tools and the Need for Empirical Validation Through In-Office Applications

Functional assessment should be one aspect of impairment rating, but not the only aspect. Diagnosis, history, and physical examination; appropriate confirmatory tests; and functional outcome scores must all be incorporated.

The rating physician using the Guides should weigh all available information, emphasizing the importance of some and deemphasizing other information, so long as it is consistent and concordant with the pathology at issue. Patients may underreport or overreport their symptom complex, and any resulting clinical outcome tool based on self-report may be scored inappropriately low or high. Examiners must exercise their ability to observe the patient perform certain functional tasks to help determine if selfreport is accurate.

1.7c Choice of Functional Assessment Tools

This edition differentiates between the relative contributions of history of clinical presentation, physical findings, objective test results, and associated functional losses to the impairment rating. Functional assessment is discussed more explicitly in most chapters of this edition and is integrated with clinical presentation, physical findings, and objective testing.

Functional assessment can be approached from a global and/or organ-specific level. Several global functional assessment scales have been developed with multiple applications (eg, Short-Form 36).44 No brief and simple-to-use scale appears available that can serve for multiorgan system functional assessment purposes. In several specific organ systems, general functional outcome scales that are well accepted exist to determine functional loss in relation to symptom severity. For example, the NYHA’s Classification of Cardiac Disease41 and the American Thoracic Society’s Impairment Classification of Dyspnea 45 have well-documented grading schemes for symptom severity which have been validated against objective measures of metabolic energy expenditure and pulmonary function testing, respectively.

For the musculoskeletal organ system, no such well-accepted, cross-validated outcome scales exist. However, there are a number of organ-specific, self-reporting functional assessment tools. These tools were typically developed to assess postsurgical outcomes. Application of such normalized data to a skewed population of patients undergoing impairment ratings is potentially misleading. These tools can generate consistent and standardized self-report data for this subgroup, which can have descriptive and analytical applications toward impairment rating. The resulting scores can be rank ordered into “no deficit; mild; moderate; severe; and extreme” deficit categories to help quantify an individual’s perceived pain, suffering, and functional result. Such self-report tests can be easily and consistently administered in the physician’s office and quickly scored by the examiner. As results are wholly based on self-report, intentional manipulation of impairment rating is possible. Therefore, when these test results tend to place an individual in an impairment grade that is higher or lower than that suggested by other parameters, the evaluator must assess the validity and consistency of conventional information before assigning a rating.

With appropriate scaling, functional scores may also be helpful in developing an impairment percentage adjustment that is organ-specific and functionally based. What this means is that the tool was originally designed to give the examiner the ability to assess a postsurgical patient’s individual test score (standardized) in relation to the normative data of the population for which it was derived (ie, “Mrs. Smith scored at the 55th percentile; based on the population mean of 50% she is slightly better than average in functional outcome.”) The results of such tools,

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.